4-3492937-ACCC-ACCCC
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_173660.5(DOK7):c.957dup(p.Lys320GlnfsTer49) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,543,892 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
DOK7
NM_173660.5 frameshift
NM_173660.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.60
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 48 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-3492937-A-AC is Pathogenic according to our data. Variant chr4-3492937-A-AC is described in ClinVar as [Likely_pathogenic]. Clinvar id is 465693.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DOK7 | NM_173660.5 | c.957dup | p.Lys320GlnfsTer49 | frameshift_variant | 7/7 | ENST00000340083.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DOK7 | ENST00000340083.6 | c.957dup | p.Lys320GlnfsTer49 | frameshift_variant | 7/7 | 1 | NM_173660.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151486Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
3
AN:
151486
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000290 AC: 4AN: 138024Hom.: 0 AF XY: 0.0000399 AC XY: 3AN XY: 75260
GnomAD3 exomes
AF:
AC:
4
AN:
138024
Hom.:
AF XY:
AC XY:
3
AN XY:
75260
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000136 AC: 19AN: 1392406Hom.: 0 Cov.: 110 AF XY: 0.0000116 AC XY: 8AN XY: 687358
GnomAD4 exome
AF:
AC:
19
AN:
1392406
Hom.:
Cov.:
110
AF XY:
AC XY:
8
AN XY:
687358
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151486Hom.: 0 Cov.: 34 AF XY: 0.0000271 AC XY: 2AN XY: 73896
GnomAD4 genome
AF:
AC:
3
AN:
151486
Hom.:
Cov.:
34
AF XY:
AC XY:
2
AN XY:
73896
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Dec 03, 2016 | This sequence change inserts 1 nucleotide in exon 7 of the DOK7 mRNA (c.957dupC), causing a frameshift at codon 320. This creates a premature translational stop signal in the last exon of the DOK7 mRNA (p.Lys320Glnfs*49). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 185 amino acids of the DOK7 protein. While this particular variant has not been reported in the literature, truncating variants in DOK7 are known to be pathogenic (PMID: 16917026) A different truncation downstream of this variant (p.1124_1127dupTGCC) has been determined to be pathogenic (PMID: 16917026, 23657916). This suggests that deletion of this region of the DOK7 protein is causative of disease. In summary, this variant is a rare duplication that is expected to disrupt the last 185 amino acids of the DOK7 protein. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Fetal akinesia deformation sequence 3 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 06, 2024 | - - |
Fetal akinesia deformation sequence 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Congenital myasthenic syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 24, 2023 | Variant summary: DOK7 c.957dupC (p.Lys320GlnfsX49) results in a premature termination codon, predicted to cause a truncation of the encoded protein, which are commonly known mechanisms for disease. Variants downstream of this position have been classified as pathogenic by our laboratory (e.g. c.1263dupC). The variant allele was found at a frequency of 2.9e-05 in 138024 control chromosomes. To our knowledge, no occurrence of c.957dupC in individuals affected with Congenital Myasthenic Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at